z-logo
open-access-imgOpen Access
Topical anesthesia versus peribulbar anesthesia in phacoemulsification cataract surgery and intraocular lens implantation
Author(s) -
Incaf Elboukhani,
Choaib Essadouni,
A. Mchachi,
L. Benhmidoune,
Abderrahim Chakib,
R. Rachid,
M. Elbelhadji
Publication year - 2020
Publication title -
journal of clinical and investigative surgery
Language(s) - English
Resource type - Journals
ISSN - 2559-5555
DOI - 10.25083/2559.5555/5.2/100.103
Subject(s) - medicine , phacoemulsification , cataract surgery , premedication , anesthesia , cataracts , intraocular pressure , blood pressure , surgery , complication , ophthalmology , visual acuity
Topical anesthesia during phacoemulsification cataract surgery has become the best choice for ophthalmologists, which broadens the indications for surgery, and eliminates the risk of peribulbar injections. The aim of our study is to assess the advantages and disadvantages, the efficacy and the tolerance of this protocol. Prospective study extending from January 2018 to December 2019, including 116 patients operated for cataracts under topical anesthesia (group 1), and 179 patients under peribulbar anesthesia (group 2). All patients were operated by phacoemulsification. The patients evaluated their pain on a visual analog scale graduated from 1 to 10. The two groups were comparable in age, gender and history of high blood pressure. All patients received premedication before surgery (Atarax). It was the first eye operated for cataracts in 79 patients in group 1 and 75 patients in group 2. The two groups did not differ significantly in systolic blood pressure rate (p= 0,36), pain score (p=0.54), duration of surgery (p=0.52), anaesthesia-related intraoperative difficulties (p=0.17), or intraoperative surgical complication rate (p=0.49) or blood oxygen saturation (p=0.74). However, in the peribulbar groups, better patient and surgeon satisfaction scores were obtained (P < .005).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here